HSACU - Health Sciences Acquisitions Corporation Announces that Shares of Common Stock and Warrants to Commence Separate Trading on or about June 21 2019
NEW YORK, June 20, 2019 /PRNewswire/ -- Health Sciences Acquisitions Corporation ("the Company") (NASDAQ: HSACU), a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, today announced that holders of the Company's units may elect to separately trade the common stock and warrants included in its units commencing on or about June 21, 2019.
The common stock and warrants will trade on the NASDAQ Capital Market ("NASDAQ") under the symbols HSAC and HSACW, respectively. Units not separated will continue to trade on NASDAQ under the symbol HSACU. After separation, the common stock and warrants may be recombined to create units.
About Health Sciences Acquisitions Corporation
Health Sciences Acquisitions Corporation is a Delaware company incorporated as a blank check company for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company's efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although the Company intends to focus on targets located North America or Europe that are developing assets in the biopharma and medical technology sectors.
Forward-Looking Statements
This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, including the successful consummation of the Company's initial public offering, are subject to risks and uncertainties, which could cause actual results to differ from the forward- looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.
For more information, please contact:
Stephanie A. Sirota
Vice President of Corporate Strategy and Corporate Communications of Health Sciences Acquisitions Corporation
Email: hsac@rtwfunds.com
SOURCE Health Sciences Acquisitions Corporation